Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06159972
Other study ID # 6035362
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 5, 2023
Est. completion date December 31, 2024

Study information

Verified date December 2023
Source Queen's University
Contact Nader M Hanna, MBBS, MSc
Phone (613) 549-6666
Email nader.hanna@queensu.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with reflux disease (heart burn), or a hiatal hernia, who do not get better with medication, may have surgery to help with their symptoms. Unfortunately, there is no agreed upon way to perform the surgery. The investigators are using a new surgical instrument called the EndoFLIP which allows surgeons to take measurements during the operation. The investigators will compare the measurements obtained during surgery with a quality of life score that we will calculate from a questionnaire.


Description:

Gastroesophageal reflux disease (GERD) has a prevalence of 30% in North America (Richter 2018), where patients can present with reflux, heartburn, dysphagia, chest pain, or a combination of symptoms. Those referred by their primary care physician to a specialist have often already failed a trial of proton pump inhibitors (PPI), thus warranting further investigation. Practice guidelines from the American College of Gastroenterologists (Katz 2013) recommend that patients undergo upper endoscopy, followed by esophageal manometry, and reflux monitoring before any surgical intervention. While these recommendations are well-founded, patient compliance with these tests remains low, since esophageal manometry and 24-hour pH testing are generally poorly tolerated, involving the placement of probes inserted nasogastrically. A qualitative study investigated patient perceptions of 24-hour pH monitoring and manometry testing (Walamies 2002) and asked 92 patients to describe their experience with manometry. Of the 84 respondents, 52% reported moderate-severe discomfort. It was shown that many patients are fearful and anxious about these tests. Some may refuse them due to their invasiveness, especially if having already undergone endoscopic evaluation. Undergoing surgery with an indeterminate diagnosis or in the absence of a full motility assessment is contraindicated by current practice guidelines and devastating consequences could occur. The lack of preoperative investigations could omit a large subset of potential surgical candidates or even lead to anti-reflux surgery in patients for the wrong diagnosis. Once a patient is considered a surgical candidate, operative management aims to reestablish the anti-reflux barrier by plicating the gastric fundus around the gastroesophageal junction (GEJ), called fundoplication. Until now, there is no established objective measure to determine how tight to make the fundoplication. Some surgeons use a bougie to estimate the diameter of the GEJ (Patterson 2000), while some use an endoscope, and others rely on their subjective judgement. A fundoplication that is too narrow can cause severe postoperative dysphagia symptoms, whereas one that is too loose may cause recurrence or worsening of GERD symptoms. A balance is required. The EndoFLIP balloon catheter allows users to measure the cross-sectional area (CSA), diameter, pressure and distensibility index (DI) of the GEJ. This can be done intraoperatively to obtain objective measures of the tightness of the fundoplication. These results may then be correlated with post-operative symptoms to determine the optimal CSA and DI in fundoplication. Previous studies have sought to address this problem but were limited by their lack of standardized EndoFLIP use (Su 2019). Symptom severity measurements were also captured too early in the post-operative period before a new baseline was established (Nwokedi 2020). This proposed study will have a defined EndoFLIP protocol that will be used to obtain all measurements. In addition, our post-operative readings will be captured no earlier than four months from the date of surgery. The investigators attempt to establish objective measurements to guide future operative interventions, thereby improving postoperative symptoms and overall patient satisfaction. During the pre-operative workup, most patients with a clinical indication for 24-hour pH monitoring and manometry testing will undergo an esophagogastroduodenoscopy (EGD). This is much better tolerated, allowing for the administration of topical anesthetic and intravenous sedating medications. EndoFLIP readings can be taken at the time of EGD, thereby decreasing the number of investigations that may prolong preoperative workup. Clinicians may be able to rely on these readings alone in select patients. Prior studies investigating the use of this novel technique have compared preoperative and post-operative CSA and DI values following a wide range of esophagogastric procedures [Attaar 2021, Ichkhanian 2020] and others have established a relationship with patient reported outcomes [Su 2020, Nwokedi 2020]. Some have compared CSA and DI in patients with and without achalasia [Carlson 2015]. Others have attempted to identify a correlation between EndoFLIP readings and anorectal manometry [Zifan 2018, Leroi 2018], and with pyloric manometry [Snape 2016]. One group of investigators [Tucker 2013] attempted to validate EndoFLIP readings with acid exposure time on pH testing and found no correlation between the two. That study was limited by its small sample size and the retrospective nature of the data, resulting in uncontrolled confounding. A true correlation between EndoFLIP measurements with 24-hour pH monitoring and esophageal manometry has yet to be identified. To summarise, a knowledge of the intra-operative EndoFLIP measurements that correlate with acceptable post-operative symptom severity scores will be useful information for surgeons performing a fundoplication (there currently is no gold standard for fundoplication creation). Secondly, if pre-operative EndoFLIP measurements correlate well with pre-operative 24-hr pH studies and manometry testing, then there is a potential for EndoFLIP to replace these invasive, uncomfortable, and poorly tolerated tests. This may result in increased patient compliance and reduced costs of pre-operative testing.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2024
Est. primary completion date July 5, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients undergoing workup for gastroesophageal reflux disease (GERD) and/or symptomatic hiatal hernia who undergo fundoplication AND who undergo fundoplication Exclusion Criteria: - Those with a previous history of hiatal hernia repair, fundoplication, esophagectomy, or gastrectomy - Inability to provide consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EndoFLIP
EndoFLIP is a small balloon catheter that is inserted through the endoscope at the time of endoscopy.

Locations

Country Name City State
Canada KHSC Kingston Ontario

Sponsors (2)

Lead Sponsor Collaborator
Dr. Wiley Chung Medtronic

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Intraoperative EndoFLIP and postoperative quality of life using the "GERD health related quality of life" score To identify the correlation between intra-operative EndoFLIP measurements of cross-sectional area, distensibility index, and contraction pattern with post-operative symptom severity score for GERD using the "GERD health related quality of life" score. 4 (four) months
Secondary Intraop EndoFLIP and preop + postop manometry and pH monitoring To identify the correlation between intra-operative EndoFLIP measurements of cross-sectional area, distensibility index with 24-hour pH monitoring, before and after fundoplication; and to identify a correlation between contraction pattern and manometry before and after fundoplication. 4 (four) months
See also
  Status Clinical Trial Phase
Recruiting NCT06084572 - Prospective Evaluation of pH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
Completed NCT03568825 - Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose N/A
Recruiting NCT04703374 - A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects Phase 1
Completed NCT04120025 - Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients N/A
Withdrawn NCT04771247 - Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy N/A
Completed NCT02575287 - Minimal Injuries From Esophagus Detected by Optical Enhancement Systemâ„¢ Associated to Optical Magnification HD Scopes N/A
Completed NCT01710800 - Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy N/A
Completed NCT00287339 - The Utility of Nexium in Chronic Cough and Reflux Disease Phase 4
Completed NCT00287391 - Sleep Disorders and Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT00629564 - An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) Phase 4
Completed NCT04243668 - ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA) N/A
Completed NCT03558477 - PK/PD Clinical Trial of YYD601 in Healthy Adult Male Phase 1
Recruiting NCT05042063 - Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease
Completed NCT05069493 - Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing
Terminated NCT04626232 - Comparison of the Sleeve Gastrectomy Technique With a Nissen Fundoplication Added to the Conventional Sleeve Gastrectomy Technique in Morbidly Obese Patients N/A
Completed NCT03238534 - Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS Phase 4
Recruiting NCT05974722 - Mesh Vs Pledgets for Repair of Paraesophageal Hernia N/A
Recruiting NCT05781347 - Stretta Versus Conservative Treatment in Obese and Non-obese N/A
Completed NCT06141577 - A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects Phase 1
Recruiting NCT05108038 - A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects Phase 1